Literature DB >> 10510381

The human antibody response to porcine xenoantigens is encoded by IGHV3-11 and IGHV3-74 IgVH germline progenitors.

M Kearns-Jonker1, J Swensson, C Ghiuzeli, W Chu, Y Osame, V Starnes, D V Cramer.   

Abstract

Preformed and induced Ab responses present a major immunological barrier to the use of pig organs for human xenotransplantation. We generated IgM and IgG gene libraries established from lymphocytes of patients treated with a bioartificial liver (BAL) containing pig hepatocytes and used these libraries to identify IgVH genes that encode human Ab responses to pig xenoantigens. Genes encoded by the VH3 family are increased in expression in patients following BAL treatment. cDNA libraries representing the VH3 gene family were generated, and the relative frequency of expression of genes used to encode the Ab response was determined at days 0, 10, and 21. Ig genes derived from the IGHV3-11 and IGHV3-74 germline progenitors increase in frequency post-BAL. The IGHV3-11 gene encodes 12% of VH3 cDNA clones expressed as IgM Abs at day 0 and 32.4-39.0% of cDNA clones encoding IgM Abs in two patients at day 10. IGHV3-11 and IGHV3-74 genes encoding IgM Abs in these patients are expressed without evidence of somatic mutation. By day 21, an isotype switch occurs and IGHV3-11 IgVH progenitors encode IgG Abs that demonstrate somatic mutation. We cloned these genes into a phagemid vector, expressed these clones as single-chain Abs, and demonstrated that the IGHV3-11 gene encodes Abs with the ability to bind to the gal alpha (1,3) gal epitope. Our results demonstrate that the xenoantibody response in humans is encoded by IgVH genes restricted to IGHV3-11 and IGHV3-74 germline progenitors. IgM Abs are expressed in germline configuration and IgG Abs demonstrate somatic mutations by day 21.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10510381

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  Anti-non-Gal-specific combination treatment with an anti-idiotypic Ab and an inhibitory small molecule mitigates the xenoantibody response.

Authors:  John M Stewart; Alice F Tarantal; Yan Chen; Nancy C Appleby; Tania I Fuentes; C Chang I Lee; Evelyn J Salvaris; Anthony J F d'Apice; Peter J Cowan; Mary Kearns-Jonker
Journal:  Xenotransplantation       Date:  2014-03-17       Impact factor: 3.907

2.  Correlation between insulin requirements and anti-galactose antibodies in patients with type 1 diabetes transplanted with neonatal pig islets.

Authors:  R Esquivel-Pérez; A L Rodriguez-Ventura; L M Dorantes; B Ramírez-González; M G López-Santos; R Valdes-Gonzalez
Journal:  Clin Exp Immunol       Date:  2011-04-19       Impact factor: 4.330

3.  Identification of the V genes encoding xenoantibodies in non-immunosuppressed rhesus monkeys.

Authors:  Annette Kleihauer; Clare R Gregory; Dominic C Borie; Andrew E Kyles; Irina Shulkin; Insiyyah Patanwala; Joanne Zahorsky-Reeves; Vaughn A Starnes; Yoko Mullen; Ivan T Todorov; Mary Kearns-Jonker
Journal:  Immunology       Date:  2005-09       Impact factor: 7.397

4.  Rhesus monkeys and baboons develop clotting factor VIII inhibitors in response to porcine endothelial cells or islets.

Authors:  John M Stewart; Alice F Tarantal; Wayne J Hawthorne; Evelyn J Salvaris; Philip J O'Connell; Mark B Nottle; Anthony J F d'Apice; Peter J Cowan; Mary Kearns-Jonker
Journal:  Xenotransplantation       Date:  2014-05-08       Impact factor: 3.907

5.  The anti-non-gal xenoantibody response to xenoantigens on gal knockout pig cells is encoded by a restricted number of germline progenitors.

Authors:  K Kiernan; I Harnden; M Gunthart; C Gregory; J Meisner; M Kearns-Jonker
Journal:  Am J Transplant       Date:  2008-07-28       Impact factor: 8.086

6.  Identification of an anti-idiotypic antibody that defines a B-cell subset(s) producing xenoantibodies in primates.

Authors:  Jacqueline Fischer-Lougheed; Clare Gregory; Zena White; Irina Shulkin; Mirja Gunthart; Mary Kearns-Jonker
Journal:  Immunology       Date:  2007-10-03       Impact factor: 7.397

Review 7.  Cancer immunotherapy for pancreatic cancer utilizing α-gal epitope/natural anti-Gal antibody reaction.

Authors:  Masahiro Tanemura; Eiji Miyoshi; Hiroaki Nagano; Hidetoshi Eguchi; Katsuyoshi Matsunami; Kiyomi Taniyama; Nobutaka Hatanaka; Hiroki Akamatsu; Masaki Mori; Yuichiro Doki
Journal:  World J Gastroenterol       Date:  2015-10-28       Impact factor: 5.742

Review 8.  Anti-Gal: an abundant human natural antibody of multiple pathogeneses and clinical benefits.

Authors:  Uri Galili
Journal:  Immunology       Date:  2013-09       Impact factor: 7.397

9.  Xenoantibody response to porcine islet cell transplantation using GTKO, CD55, CD59, and fucosyltransferase multiple transgenic donors.

Authors:  Yan Chen; John M Stewart; Mirja Gunthart; Wayne J Hawthorne; Evelyn J Salvaris; Philip J O'Connell; Mark B Nottle; Anthony J F d'Apice; Peter J Cowan; Mary Kearns-Jonker
Journal:  Xenotransplantation       Date:  2014-03-20       Impact factor: 3.907

10.  Similarities in the immunoglobulin response and VH gene usage in rhesus monkeys and humans exposed to porcine hepatocytes.

Authors:  Joanne L Zahorsky-Reeves; Clare R Gregory; Donald V Cramer; Insiyyah Y Patanwala; Andrew E Kyles; Dominic C Borie; Mary K Kearns-Jonker
Journal:  BMC Immunol       Date:  2006-03-20       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.